Get started
Author

Guixin Ding

Observed name: Ding, Guixin
Observed institutions: Qingdao University, Guizhou University, American Urological Association, European Association of Urology, Yuhuangding Hospital, National Comprehensive Cancer Network
ORCID: 0009-0009-7215-3261
Observed ORCID: 0009-0009-7215-3261
OpenAlex ID: A5032675748
Lactate-driven lactylation of HNRNPA1 orchestrates PKM2 splicing and glycolytic reprogramming in bladder cancer
2025 · Tianqi Wang, Xiaohong Ma, et al. · Journal of Experimental & Clinical Cancer Research · 18
A comparative analysis of perioperative complications and biochemical recurrence between standard and extended pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy: a systematic review and meta-analysis
2023 · Guixin Ding, Gonglin Tang, et al. · International Journal of Surgery · 14
Expression of EPB41L2 in Cancer-Associated Fibroblasts: Prognostic Implications for Bladder Cancer and Response to Immunotherapy
2023 · Tianqi Wang, Guixin Ding, et al. · Archives of Medical Research · 10
Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection
2024 · Xidong Wang, Gang Wu, et al. · Therapeutic Advances in Urology · 7
Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
2023 · Guixin Ding, Tianqi Wang, et al. · Frontiers in Immunology · 7
PDF
Efficacy and safety evaluation of androgen deprivation therapy-based combinations for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis
2024 · Tianqi Wang, Xiaoyu Wang, et al. · British Journal of Cancer · 6
PDF
A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis–immune-related gene signature
2023 · Guixin Ding, Tianqi Wang, et al. · Heliyon · 6
The pooled analysis evaluates the therapeutic efficacy of desmopressin combined with anticholinergic drugs in the treatment of pediatric nocturnal enuresis
2023 · Gonglin Tang, Hongquan Liu, et al. · Neurourology and Urodynamics · 5
PDF
The Efficacy of Cyclooxygenase-2 Inhibitors for the Male Treatment of Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis
2023 · Gonglin Tang, Ming Liu, et al. · American Journal of Men s Health · 5
PDF
Comparison of ureteroscopic lithotripsy and laparoscopic ureterolithotomy in the treatment of large proximal ureteral stones in developing countries: a systematic review and meta-analysis
2025 · Youwei Chi, Fengze Sun, et al. · International Journal of Surgery · 4
HROB as a novel prognostic biomarker associated with tumor immunity in clear cell renal cell carcinoma: A comprehensive analysis integrating bulk sequencing
2024 · Guixin Ding, Fengze Sun, et al. · Asian Journal of Surgery · 3
Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
2023 · Gonglin Tang, Kai Sun, et al. · International Journal of General Medicine · 3
PDF
Disease burden of infertility in five East Asian countries from 1990 to 2021 and prediction for 2050: An analysis of the Global Burden of Disease study 2021
2025 · Fengze Sun, Wenyu Wang, et al. · PLoS ONE · 2
PDF
Multi-omics analysis of Prolyl 3-hydroxylase 1 as a prognostic biomarker for immune infiltration in ccRCC
2024 · Guixin Ding, Tianqi Wang, et al. · npj Precision Oncology · 2
PDF
Renal Metastasis Arising From a Pulmonary Adenoid Cystic Carcinoma: A Rare Case Report and Literature Review
2024 · Guixin Ding, Tianqi Wang, et al. · American Journal of Men s Health · 2
Re: Gallagher K, MacLennan S, Bhatt N, et al. RESECT: a randomised controlled trial of audit and feedback in non–muscle-invasive bladder cancer surgery. Eur Urol. In Press. https://doi.org/10.1016/j.eururo.2025.09.4174
2026 · Guixin Ding, Jipeng Wang, et al. · International Journal of Surgery · 1
Human-induced pluripotent stem cell derived exosomal miR-103a-3p accelerate urethral injury recovery by promoting angiogenesis via TGFBR3/VEGF/FAK axis
2026 · Fengze Sun, Hongquan Liu, et al. · Stem Cell Research & Therapy · 1
Multi-omics analysis of zinc finger protein 683 as a prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
2025 · Yicheng Guo, Yini Wang, et al. · BMC Cancer · 1
ACAP1 could serve as a novel prognostic biomarker associated with tumor immunity in clear-cell renal cell carcinoma: A comprehensive analysis by integrating bulk and single-cell sequencing
2024 · Guixin Ding, Yingying Yang, et al. · Asian Journal of Surgery · 1
Re: Khan S, Papa N, Kneebone A, et al. Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol. 2026;89:512–520
2026 · Guixin Ding, Jipeng Wang, et al. · European Urology
Re: Ghadjar P, Hayoz S, Zwahlen DR, et al. Dose intensified versus conventional dose salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy long term data from the SAKK 09/10 randomised phase 3 trial. Eur Urol. In press. https: //doi.org/10.1016/j.eururo.2025.12.020
2026 · Guixin Ding, Jipeng Wang, et al. · International Journal of Surgery
AKAP7 is a prognostic biomarker involved in immune infiltration of bladder urothelial carcinoma and correlated with ferroptosis
2026 · Hongquan Liu, Qiancheng Mao, et al. · Discover Oncology
EPB41L family serves as a prognostic biomarker for kidney renal clear cell carcinoma
2026 · Gonglin Tang, Kai Sun, et al. · Cell Adhesion & Migration
Comprehensive analysis of COLGALT1 in tumor microenvironment regulation and prognosis of clear cell renal cell carcinoma
2026 · Yicheng Guo, Bin Wang, et al. · Clinical and Experimental Medicine
PDF
EPB41L family serves as a prognostic biomarker for kidney renal clear cell carcinoma
2026 · Tang, Gonglin, Sun, Kai, et al. · Figshare
Works count: 36
Citation count: 98
H-index: 6
I10-index: 3
Year
Topic
Type